{"anticipatedPostingDate":"2027-06","denomUnitsSelected":"Participants","description":"An AE is defined as any untoward medical occurrence in a clinical investigation participant administered an investigational medicinal product; it does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (example, a clinically significant abnormal laboratory finding), symptom, or disease temporally associated with the use of a drug, whether or not it is considered related to the drug.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 52 months","title":"Percentage of Participants With Adverse Events (AEs)","type":"SECONDARY"}